How to Manage Asthma – Involve the Community – International Business Times AU


International Business Times AU

How to Manage Asthma – Involve the Community
International Business Times AU
Asthma, characterized by the infamous wheezing sounds that people make, is a disease that affects the breathing passages of the lungs. The problem of asthma is so widespread that, according to the
Community-based care coordination effective for real world asthma management EurekAlert (press release)

all 5 news articles »

View full post on asthma – Google News

KALBITOR® (ecallantide) Data in HAE Presented at the American College of … – Business Wire (press release)

KALBITOR® (ecallantide) Data in HAE Presented at the American College of
Business Wire (press release)
(NASDAQ: DYAX) announced today that two oral and two poster presentations featuring KALBITOR ® (ecallantide) data in hereditary angioedema (HAE) were presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Meeting held
KALBITOR(R) (ecallantide) Data in HAE Presented at the American College of MarketWatch (press release)

all 13 news articles »

View full post on asthma – Google News

Merck Dulera shows efficacy in COPD treatment – Pharmaceutical Business Review

Merck Dulera shows efficacy in COPD treatment
Pharmaceutical Business Review
Dulera Inhalation Aerosol, which is used to treat asthma combines mometasone furoate, an inhaled corticosteroid, and formoterol fumarate, a long-acting beta2-agonist. The two 26-week, multicenter, double-blind, placebo controlled trials comprising 2251
Merck Announces Presentation of Phase III Investigational Studies Evaluating MarketWatch (press release)

all 12 news articles »

View full post on asthma – Google News

New Legislation and Occupational Asthma in Australia – International Business Times AU

New Legislation and Occupational Asthma in Australia
International Business Times AU
Yet the quality of indoor air, the air that we breathe, is of paramount importance because one manifestation of poor quality air is occupational asthma. It's caused by exposure to airborne substances known as asthmagens. Well over 200 respiratory

and more »

View full post on asthma – Google News

New Legislation and Occupational Asthma in Australia – International Business Times AU

New Legislation and Occupational Asthma in Australia
International Business Times AU
Yet the quality of indoor air, the air that we breathe, is of paramount importance because one manifestation of poor quality air is occupational asthma. It's caused by exposure to airborne substances known as asthmagens. Well over 200 respiratory

and more »

View full post on asthma – Google News

Kissei funds for MediciNova asthma drug development – Pharmaceutical Business Review

Kissei funds for MediciNova asthma drug development
Pharmaceutical Business Review
Kissei Pharmaceutical is funding $2.5m to support further clinical development of MediciNova's MN-221 to treat acute exacerbations of asthma or chronic obstructive pulmonary disease (COPD). As per the license agreenent signed between the two companies
MediciNova to Receive $2.5 Million Payment From Kissei Pharmaceutical Co. Ltd MarketWatch (press release)
Kissei To Pay MediciNova $2.5 Mln To Support Clinical Development Of MN-221RTT News
MediciNova Inc expects USD2.5m from Kissei Pharmaceutical Co Ltd for MN-221 Middle East North Africa Financial Network

all 10 news articles »

View full post on asthma – Google News